Cargando…
Serum amyloid A augments the atherogenic effects of cholesteryl ester transfer protein
Serum amyloid A (SAA) is predictive of CVD in humans and causes atherosclerosis in mice. SAA has many proatherogenic effects in vitro. However, HDL, the major carrier of SAA in the circulation, masks these effects. The remodeling of HDL by cholesteryl ester transfer protein (CETP) liberates SAA rest...
Autores principales: | Ji, Ailing, Trumbauer, Andrea C., Noffsinger, Victoria P., de Beer, Frederick C., Webb, Nancy R., Tannock, Lisa R., Shridas, Preetha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165456/ https://www.ncbi.nlm.nih.gov/pubmed/37004910 http://dx.doi.org/10.1016/j.jlr.2023.100365 |
Ejemplares similares
-
Serum Amyloid A is not obligatory for high-fat, high-sucrose, cholesterol-fed diet-induced obesity and its metabolic and inflammatory complications
por: Ji, Ailing, et al.
Publicado: (2022) -
Role of Serum Amyloid A in Abdominal Aortic Aneurysm and Related Cardiovascular Diseases
por: Shridas, Preetha, et al.
Publicado: (2021) -
Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
por: Chapman, M. John, et al.
Publicado: (2010) -
Assessing the mechanisms of cholesteryl ester transfer protein inhibitors
por: Zhang, Meng, et al.
Publicado: (2017) -
The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A
por: de Beer, Maria C., et al.
Publicado: (2013)